The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response ; day:23 ; month:11 ; year:2021 ; extent:1
The chemical record ; (23.11.2021) (gesamt 1)
- Urheber
-
Stergiou, Natascha
Urschbach, Moritz
Gabba, Adele
Schmitt, Edgar
Kunz, Horst
Besenius, Pol
- DOI
-
10.1002/tcr.202100182
- URN
-
urn:nbn:de:101:1-2021112314240178294890
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stergiou, Natascha
- Urschbach, Moritz
- Gabba, Adele
- Schmitt, Edgar
- Kunz, Horst
- Besenius, Pol
Ähnliche Objekte (12)
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation
High level in vivo mucin-type glycosylation in Escherichia coli
Recombinant and synthetic vaccines
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota
Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
Synthetic carbohydrate-based vaccines: challenges and opportunities
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation
High level in vivo mucin-type glycosylation in Escherichia coli
Recombinant and synthetic vaccines
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota
Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
Synthetic carbohydrate-based vaccines: challenges and opportunities
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation
High level in vivo mucin-type glycosylation in Escherichia coli
Recombinant and synthetic vaccines
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota
Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response